Héctor García‐Calderó

2.0k total citations
28 papers, 1.6k citations indexed

About

Héctor García‐Calderó is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Héctor García‐Calderó has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 17 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Héctor García‐Calderó's work include Liver Disease and Transplantation (21 papers), Liver Disease Diagnosis and Treatment (17 papers) and Liver physiology and pathology (7 papers). Héctor García‐Calderó is often cited by papers focused on Liver Disease and Transplantation (21 papers), Liver Disease Diagnosis and Treatment (17 papers) and Liver physiology and pathology (7 papers). Héctor García‐Calderó collaborates with scholars based in Spain, Switzerland and United Kingdom. Héctor García‐Calderó's co-authors include Juan Carlos García‐Pagán, Jordi Gracia‐Sancho, Jaime Bosch, Aina Rodríguez‐Vilarrupla, Juan G. Abraldeṣ, Jaume Bosch, Bàrbara Laviña, Erica Lafoz, Guillermo García‐Cardeña and Marina Vilaseca and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Héctor García‐Calderó

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Héctor García‐Calderó Spain 20 1.1k 1.1k 411 204 196 28 1.6k
Yuichi Yamazaki Japan 17 460 0.4× 398 0.4× 296 0.7× 233 1.1× 157 0.8× 75 1.0k
Cristiana Bertolani Italy 12 1.0k 0.9× 514 0.5× 234 0.6× 265 1.3× 128 0.7× 15 1.5k
Len Verbeke Belgium 13 645 0.6× 557 0.5× 427 1.0× 174 0.9× 112 0.6× 23 1.2k
Hiroaki Takaya Japan 19 594 0.5× 483 0.4× 203 0.5× 296 1.5× 80 0.4× 82 1.2k
Hideyuki Kojima Japan 21 610 0.5× 447 0.4× 231 0.6× 180 0.9× 76 0.4× 57 1.2k
Sander Lefere Belgium 18 789 0.7× 391 0.3× 260 0.6× 274 1.3× 45 0.2× 55 1.2k
Aileen Dela Peňa Australia 12 639 0.6× 290 0.3× 253 0.6× 359 1.8× 78 0.4× 14 1.3k
Geoff Farrell Australia 11 1.2k 1.1× 516 0.5× 216 0.5× 310 1.5× 51 0.3× 15 1.5k
Montserrat Moreno Spain 15 1.0k 0.9× 598 0.5× 141 0.3× 220 1.1× 79 0.4× 17 1.4k
Marlene Domínguez Spain 12 1.1k 1.0× 619 0.6× 149 0.4× 217 1.1× 112 0.6× 14 1.5k

Countries citing papers authored by Héctor García‐Calderó

Since Specialization
Citations

This map shows the geographic impact of Héctor García‐Calderó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Héctor García‐Calderó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Héctor García‐Calderó more than expected).

Fields of papers citing papers by Héctor García‐Calderó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Héctor García‐Calderó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Héctor García‐Calderó. The network helps show where Héctor García‐Calderó may publish in the future.

Co-authorship network of co-authors of Héctor García‐Calderó

This figure shows the co-authorship network connecting the top 25 collaborators of Héctor García‐Calderó. A scholar is included among the top collaborators of Héctor García‐Calderó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Héctor García‐Calderó. Héctor García‐Calderó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shalaby, Sarah, Annabel Blasi, Yiliam Fundora, et al.. (2025). Isolation and immortalization of human portal vein endothelial cells: A novel research tool for studying splanchnic vasculature. JHEP Reports. 7(10). 101543–101543.
2.
Rovira, Jordi, María José Ramírez-Bajo, Elisenda Bañón-Maneus, et al.. (2024). Mediterranean Diet Pattern: Potential Impact on the Different Altered Pathways Related to Cardiovascular Risk in Advanced Chronic Kidney Disease. Nutrients. 16(21). 3739–3739. 1 indexed citations
3.
Campreciós, Genís, Marina Vilaseca, Dinesh Mani Tripathi, et al.. (2023). Interspecies transcriptomic comparison identifies a potential porto‐sinusoidal vascular disorder rat model suitable for in vivo drug testing. Liver International. 44(1). 180–190. 1 indexed citations
4.
Campreciós, Genís, Carla Montironi, Maria Ruart, et al.. (2023). Lack of endothelial autophagy does not impair liver regeneration after partial hepatectomy in mice. Liver International. 43(10). 2302–2308.
5.
Youssef, L., F. Crovetto, Rui V. Simões, et al.. (2022). The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics. Life. 12(1). 86–86. 17 indexed citations
6.
Campreciós, Genís, Maria Ruart, Carla Montironi, et al.. (2021). Spermidine Supplementation Protects the Liver Endothelium from Liver Damage in Mice. Nutrients. 13(11). 3700–3700. 7 indexed citations
7.
Youssef, L., Jezid Miranda, Miquel Blasco, et al.. (2021). Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics. Scientific Reports. 11(1). 3048–3048. 41 indexed citations
8.
Pietrosi, Giada, Anabel Fernández‐Iglesias, Mariangela Pampalone, et al.. (2020). Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats. Liver International. 40(10). 2500–2514. 23 indexed citations
9.
Gracia‐Sancho, Jordi, Martí Ortega‐Ribera, Raquel Maeso‐Díaz, et al.. (2019). Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte‐Mediated Paracrine Mechanism. Hepatology Communications. 3(7). 987–1000. 45 indexed citations
10.
Tripathi, Dinesh Mani, Marina Vilaseca, Erica Lafoz, et al.. (2018). Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension. Gastroenterology. 155(5). 1564–1577. 102 indexed citations
11.
Rosado, Eugenio, Aina Rodríguez‐Vilarrupla, Jordi Gracia‐Sancho, et al.. (2013). Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats. Hepatology. 58(4). 1424–1435. 37 indexed citations
12.
Gracia‐Sancho, Jordi, Héctor García‐Calderó, Diana Hide, et al.. (2013). Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. Journal of Hepatology. 58(6). 1140–1146. 56 indexed citations
13.
Rodríguez‐Vilarrupla, Aina, Bàrbara Laviña, Héctor García‐Calderó, et al.. (2012). PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats. Journal of Hepatology. 56(5). 1033–1039. 79 indexed citations
14.
Pasarín, Marcos, Vincenzo La Mura, Jordi Gracia‐Sancho, et al.. (2012). Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD. PLoS ONE. 7(4). e32785–e32785. 200 indexed citations
15.
Russo, Lucia, Jordi Gracia‐Sancho, Héctor García‐Calderó, et al.. (2011). Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers. Hepatology. 55(3). 921–930. 96 indexed citations
16.
García‐Calderó, Héctor, Aina Rodríguez‐Vilarrupla, Jordi Gracia‐Sancho, et al.. (2010). Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats. Journal of Hepatology. 54(4). 660–665. 38 indexed citations
17.
Gracia‐Sancho, Jordi, Bàrbara Laviña, Aina Rodríguez‐Vilarrupla, et al.. (2008). Increased oxidative stress in cirrhotic rat livers. Hepatology. 47(4). 1248–1256. 119 indexed citations
18.
Rodríguez‐Vilarrupla, Aina, R. Deulofeu, Héctor García‐Calderó, et al.. (2008). Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats. Journal of Hepatology. 49(2). 192–197. 36 indexed citations
19.
Abraldeṣ, Juan G., Aina Rodríguez‐Vilarrupla, Mariona Graupera, et al.. (2007). Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. Journal of Hepatology. 46(6). 1040–1046. 186 indexed citations
20.
Gracia‐Sancho, Jordi, Bàrbara Laviña, Aina Rodríguez‐Vilarrupla, et al.. (2007). Enhanced vasoconstrictor prostanoid production by sinusoidal endothelial cells increases portal perfusion pressure in cirrhotic rat livers. Journal of Hepatology. 47(2). 220–227. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Yamazaki Breakdown of academic impact, for papers by Cristiana Bertolani Breakdown of academic impact, for papers by Len Verbeke Breakdown of academic impact, for papers by Hiroaki Takaya Breakdown of academic impact, for papers by Hideyuki Kojima Breakdown of academic impact, for papers by Sander Lefere Breakdown of academic impact, for papers by Aileen Dela Peňa Breakdown of academic impact, for papers by Geoff Farrell Breakdown of academic impact, for papers by Montserrat Moreno Breakdown of academic impact, for papers by Marlene Domínguez
Rankless by CCL
2026